We are live on
!
Find out more
BG
Bahl & Gaynor Portfolio holdings
AUM
$19.8B
1-Year Est. Return
19.53%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.38B
AUM Growth
+$231M
(+3.2%)
Cap. Flow
+$238M
Cap. Flow
% of AUM
3.22%
Top 10 Holdings %
Top 10 Hldgs %
23.76%
Holding
443
New
26
Increased
211
Reduced
155
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$135M |
| 2 |
PepsiCo
PEP
|
+$65.3M |
| 3 |
PNC Financial Services
PNC
|
+$61.9M |
| 4 |
Home Depot
HD
|
+$55.7M |
| 5 |
Hasbro
HAS
|
+$48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$80.6M |
| 2 |
Johnson & Johnson
JNJ
|
+$67.1M |
| 3 |
US Bancorp
USB
|
+$65.3M |
| 4 |
McDonald's
MCD
|
+$50.1M |
| 5 |
Oneok
OKE
|
+$49.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.18% |
| 2 | Consumer Staples | 15.63% |
| 3 | Technology | 14.71% |
| 4 | Financials | 12.61% |
| 5 | Industrials | 11.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Clorox
CLX
$12.8B
| $4M | 0.05% |
36,211
+245
| +0.7% | +$26.6K |
|
127
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $3.93M | 0.05% |
96,229
-4,662
| -5% | -$190K |
|
128
Duke Energy
DUK
$96.6B
| $3.83M | 0.05% |
49,838
+860
| +2% | +$69.8K |
|
|
BCPC
129
Balchem Corp
BCPC
$5.75B
| $3.78M | 0.05% |
68,234
-5,221
| -7% | -$299K |
|
|
ARG
130
DELISTED
Airgas Inc
ARG
| $3.73M | 0.05% |
35,152
-2,200
| -6% | -$250K |
|
131
Colgate-Palmolive
CL
$74.1B
| $3.67M | 0.05% |
52,858
-671
| -1% | -$46.4K |
|
|
132
Oneok
OKE
$55.4B
| $3.65M | 0.05% |
75,659
-1,089,094
| -94% | -$49.8M |
|
133
State Street Technology Select Sector SPDR ETF
XLK
$122B
| $3.58M | 0.05% |
172,682
-4,300
| -2% | -$89.6K |
|
134
Phillips 66
PSX
$82.4B
| $3.47M | 0.05% |
44,104
-975
| -2% | -$71.6K |
|
135
iShares MSCI EAFE ETF
EFA
$79.4B
| $3.46M | 0.05% |
53,855
+2,050
| +4% | +$129K |
|
136
Sysco
SYY
$40.4B
| $3.36M | 0.05% |
89,055
-679
| -0.8% | -$26.8K |
|
137
Coherent
COHR
$65.4B
| $3.3M | 0.04% |
178,647
-14,740
| -8% | -$243K |
|
138
Walmart Inc
WMT
$892B
| $3.29M | 0.04% |
120,123
-7,971
| -6% | -$226K |
|
139
Diageo
DEO
$51.6B
| $3.18M | 0.04% |
28,780
+282
| +1% | +$32.5K |
|
|
PDCO
140
DELISTED
Patterson Companies, Inc.
PDCO
| $3.18M | 0.04% |
65,204
-815
| -1% | -$40.6K |
|
141
W.W. Grainger
GWW
$60.4B
| $3.16M | 0.04% |
13,385
+4
| +0% | +$954 |
|
|
HDV
142
iShares Core High Dividend ETF
HDV
$14.8B
| $3.11M | 0.04% |
207,125
-342,650
| -62% | -$5.24M |
|
|
HUB.B
143
DELISTED
HUBBELL INC CL-B
HUB.B
| $3.07M | 0.04% |
28,040
| – | – |
|
144
Intuitive Surgical
ISRG
$132B
| $3.01M | 0.04% |
53,631
-10,710
| -17% | -$606K |
|
145
Microchip Technology
MCHP
$40.4B
| $3M | 0.04% |
122,660
+1,190
| +1% | +$28.7K |
|
146
Southern Company
SO
$107B
| $2.98M | 0.04% |
67,343
-1,970
| -3% | -$93.6K |
|
147
Target
TGT
$66.8B
| $2.85M | 0.04% |
34,777
-1,300
| -4% | -$100K |
|
148
Horace Mann Educators
HMN
$2.19B
| $2.73M | 0.04% |
79,903
-4,942
| -6% | -$159K |
|
|
MON
149
DELISTED
Monsanto Co
MON
| $2.72M | 0.04% |
24,183
+95
| +0.4% | +$11.3K |
|
|
GAS
150
DELISTED
AGL Resources Inc
GAS
| $2.69M | 0.04% |
54,130
-3,405
| -6% | -$177K |
|
Similar funds
NIM
HHII
SPIA
MIM
EIM
OSAM
P
Bahl & Gaynor's Q1 2015 Portfolio in Review
As of Q1 2015, Bahl & Gaynor held 443 positions worth $7.38B, up 3.2% from $7.15B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Bahl & Gaynor deployed $238M of net new capital in Q1 2015, opening 26 new positions and adding to 211 existing holdings. Its largest new stake was Blackstone: 24,777 shares worth $946K.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was Baxter International, an estimated $80.6M trimmed.
- Bahl & Gaynor's largest Q1 2015 buy was Blackstone: 24,777 shares worth $946K.
- Bahl & Gaynor added most to Pfizer in Q1 2015, an estimated $135M increase.
- Bahl & Gaynor's biggest Q1 2015 reduction was Baxter International, cutting an estimated $80.6M.
- Bahl & Gaynor fully exited MWI VETERINARY SUPPLY, INC. in Q1 2015, selling an estimated $650K.
- Bahl & Gaynor's ten largest holdings make up 24% of its $7.38B portfolio in Q1 2015.
- Bahl & Gaynor opened 26 new positions and closed 11 in Q1 2015.
- Bahl & Gaynor's portfolio value rose 3.2% quarter-over-quarter to $7.38B.
Based on Bahl & Gaynor's 13F filing for Q1 2015, filed 12 May 2015.